Black Bird Biotech, Inc.
BBBT · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -69.5% | 75% | -38.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36% | 54.1% | 45.8% | 12.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -276.5% | -731.3% | -1,119.5% | -1,047.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,333.2% | -1,524.2% | -6,109.6% | -1,995.4% |
| EPS | -0 | -0 | -0.001 | -0.001 |
| % Growth | 66.7% | 70% | -25% | – |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 1,457 | 635 | 433 | 311 |
| Weighted Avg Shares Out Dil | 1,457 | 635 | 433 | 311 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1,059.3% | -721.7% | -1,104.3% | -1,036.8% |